Certificate in Lifestyle Medicine

---

LIVEACCMEIN-PERSON

Friday, September 8, 2023, 1:00 PM - Tuesday, September 12, 2023, 7:15 PM, Weill Cornell Medicine-Qatar, Doha, Qatar

The Certificate in Lifestyle Medicine (CLM) is a 60-hour certificate program, administered by the Institute for Population Health at Weill Cornell Medicine-Qatar, which will provide healthcare practitioners with lifestyle medicine education and competencies to aid in the evaluation, prevention and management of lifestyle-related chronic health conditions to reduce chronic disease morbidity and the suffering associated with it. Additionally, the course will enable healthcare practitioners to engage in dialogue and meaningful discussions with their patients about the potential for lifestyle medicine ultimately leading to improved overall quality of life and patient outcomes.

The course will be delivered by means of didactic lectures, small group interactive discussions, review of clinical cases, and distance online learning. There are two components to the course, which must be successfully completed to meet the course requirements in order to receive the Certificate in Lifestyle Medicine. The two components are a) attendance and participation in the onsite/in-person 30-hour unit comprising lectures and interactive discussions, b) self-study/online 30-hour unit, which requires completing the Foundations of Lifestyle Medicine Board Review Course, an evidence-based course designed to provide an overview of essential elements of lifestyle medicine. 

Please note that the onsite / in-person 30-hour unit will take place in Weill Cornell Medicine-Qatar, Doha, Qatar

1. 1) Discuss lifestyle medicine and its competencies.
2. 2) Examine the evidence of lifestyle medicine interventions in the prevention and management of chronic disease.
3. 3) Review relevant lifestyle medicine specific topics such as clinical processes, emotional and mental wellbeing, nutrition science, physical activity, social relationships and connectedness, sleep hygiene, managing tobacco and other addictions and behavior change.
4. 4) Summarize lifestyle medicine prescriptions for various chronic diseases.

ACCME Accreditation Statement  The Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians ACCME Credit Designation Statement The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 30.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. DHP Accreditation Statement Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Department of Healthcare Professions - Accreditation Section (DHP-AS). DHP Credit Designation Statement This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health’s Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 30 hours.

Disclosure of Relationships/Content Validity 

It is the policy of Weill Cornell Medicine-Qatar to adhere to Ministry of Public Health’s Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias.

Scientific Planning Committee

Khalafalla Eltoum Babikir, Mark Santos, Raji Anand, Rakhi Thakur, Rejeena Adayakandi, Ravinder Mamtani, Samaah Chalil, Sandhya Vijayakumar, Sohaila Cheema, Yasmeen Kalverts:

• Have no relevant financial relationship to disclose. 
• Will not be discussing unlabeled/unapproved use of drugs or products.

Course Directors

Ravinder Mamtani, Sohaila Cheema:

• Have no relevant financial relationship to disclose. 
• Will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty

Ahmad Almulla, Benjamin Kligler, Javaid Sheikh, Ravinder Mamtani, Sarah Burshan, Shahrad Taheri, Simon Matthews, Sohaila Cheema, Stephan Herzog:

• Have no relevant financial relationship to disclose. 
• Will not be discussing unlabeled/unapproved use of drugs or products. 

Wayne Dysinger:

• Has disclosed the following relationship : Ownership interest, Lifestyle Medical.
• Will not be discussing unlabeled/unapproved use of drugs or products.

 

Course Administrator

Yasmeen Kalverts:

• Has no relevant financial relationships to disclose.
• Will not be discussing unlabeled/unapproved use of drugs or products. 

---

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

---

Evaluation

An evaluation will be conducted online post activity. All participants are required to complete the evaluation to receive a certificate. The evaluation allows us to assess the degree to which the activity met its objectives. It will also guide the planning of future activities and inform decisions about improving the educational program.

Certificate in Lifestyle Medicine

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.